Enzymotec Ltd. to Report Fourth Quarter and Fiscal Year 2013 Financial Results

MIGDAL HA'EMEQ, Israel, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2013 on Thursday, February 13, 2014, before the market opens. Following the release, the Company will host a conference call to discuss these results with additional comments and details. Participating on the call will be Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer.

The conference call is scheduled to begin at 8:30 a.m. ET on Thursday, February 13, 2014. Listeners in North America may dial 718-971-5738 and international listeners may dial +44(0)20-3427-1907 along with confirmation code 2605859 to access the live call. A telephonic playback will be available after the call through Thursday, February 27, 2014. Participants in North America may dial 347-366-9565 and international participants may dial +44(0)20-3427-0598 along with the confirmation code 2605859 to hear the playback.

The call will also be broadcast live over the Internet, hosted at the Investors section of Enzymotec's website at http://ir.enzymotec.com, and will be archived online within one hour of its completion through Thursday, February 27, 2014.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.

CONTACT: ICR Katie Turner 646-277-1228 Katie.Turner@icrinc.com John Mills 310-954-1105 John.Mills@icrinc.comSource:Enzymotec Ltd.